Campus, Baby Girl .

HRN: 27-24-61  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/09/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/09/2025
06/16/2025
IV
14mg
Q48
PNSB
Waiting Final Action 
06/09/2025
AMPICILLIN 250MG (VIAL)
06/09/2025
06/16/2025
IV
38mg
Q12
PNSB
Waiting Final Action 
06/17/2025
CEFTAZIDIME 1GM (VIAL)
06/17/2025
06/23/2025
IV
21mg
Q12
Sepsis
Waiting Final Action 
06/17/2025
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
06/17/2025
06/29/2025
IVTT
14mg As LD Then 8.4mg
Q48
Neonatal Sepsis
Waiting Final Action 
06/17/2025
GENTAMICIN 40MG/ML, 2ML (AMP)
06/17/2025
06/27/2025
IVTT
3mg
Q36
Neonatal Sepsis
Waiting Final Action 
06/22/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/22/2025
06/29/2025
IV
70mg
Q12
Neonatal Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: